Literature DB >> 26008832

Global extent of chloroquine-resistant Plasmodium vivax - Authors' reply.

Ric N Price1, Lorenz von Seidlein2, Neena Valecha3, Francois Nosten4, J Kevin Baird5, Nicholas J White6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26008832      PMCID： PMC4629410          DOI： 10.1016/S1473-3099(15)00018-3

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  4 in total

Review 1.  Artemisinin combination therapy for vivax malaria.

Authors:  Nicholas M Douglas; Nicholas M Anstey; Brian J Angus; Francois Nosten; Ric N Price
Journal:  Lancet Infect Dis       Date:  2010-06       Impact factor: 25.071

2.  Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar.

Authors:  Lili Yuan; Ying Wang; Daniel M Parker; Bhavna Gupta; Zhaoqing Yang; Huaie Liu; Qi Fan; Yaming Cao; Yuping Xiao; Ming-chieh Lee; Guofa Zhou; Guiyun Yan; J Kevin Baird; Liwang Cui
Journal:  Antimicrob Agents Chemother       Date:  2014-12-15       Impact factor: 5.191

3.  Monitoring Plasmodium vivax chloroquine sensitivity along China-Myanmar border of Yunnan Province, China during 2008-2013.

Authors:  Hui Liu; Heng-lin Yang; Lin-hua Tang; Xing-liang Li; Fang Huang; Jia-zhi Wang; Chun-fu Li; Heng-ye Wang; Ren-hua Nie; Xiang-rui Guo; Ying-xue Lin; Mei Li; Jian-Wei Xu
Journal:  Malar J       Date:  2014-09-15       Impact factor: 2.979

Review 4.  Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis.

Authors:  Ric N Price; Lorenz von Seidlein; Neena Valecha; Francois Nosten; J Kevin Baird; Nicholas J White
Journal:  Lancet Infect Dis       Date:  2014-09-08       Impact factor: 25.071
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.